Clinical Trial to Evaluate the Chronic Efficacy of OC-01 Nasal Spray on Signs of Dry Eye Disease (The MYSTIC Study)

Clinical trial NCT03873246 · COMPLETED

Trial details

NCT number: NCT03873246
Sponsor: Oyster Point Pharma, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Dry Eye Disease

Start date: 2019-02-18
Primary completion: 2020-01-07
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.